RNA Editing in the Lung: Programmable Nucleases & Next-Gen Inhaled Delivery for Respiratory Disease

• Exploring next-generation RNA modalities from programmable nucleases to emerging enzyme systems for therapeutic use in the lung
• Case study: Leveraging a Cas13 platform to counter respiratory viral infections
• Designing inhalable delivery vehicles for safe, efficient deposition throughout the airways

Speakers:

Sabine Maamari

Chief Operating Officer

Avocet Bio